Guangzhou Magpie Pharmaceuticals Co., Ltd.
PrivateLast Round
Early Funding
Apr 20, 2020
Est. Valuation
$123.9M
Total Funding Raised
$28.88M
Company Overview
Guangzhou Magpie Pharmaceuticals Co., Ltd. operates in Healthcare & Life Sciences and is based in Guangzhou. Its latest recorded funding round was an Early Funding round in April 2020.
Guangzhou Magpie Pharmaceuticals Co., Ltd. is a biotechnology company that develops innovative small molecule drugs for the treatment of cardiovascular, cerebrovascular, neurodegenerative, and mitochondrial dysfunction diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Guangzhou Magpie Pharmaceuticals Co., Ltd. Comparables
Compare Guangzhou Magpie Pharmaceuticals Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nanjing NeuroDawn Pharmaceutical Co., Ltd. | 80% | |
| Prilenia Therapeutics | 74% | |
| QurAlis | 74% |
For institutional investors. Book with your work email.
Guangzhou Magpie Pharmaceuticals Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 20, 2020 | ||||
| Series B | Feb 12, 2019 | ||||
| Series A Extension | Sep 1, 2017 | ||||
| Series A | Dec 1, 2016 |
For institutional investors. Book with your work email.
Guangzhou Magpie Pharmaceuticals Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shenzhen Sangel Venture Capital | Series B |
| Guoqian Investment | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 271% MoM.
- Apr 20, 2020
$14.1M raised from Zhejiang CONBA Pharmaceutical Co Ltd.
For institutional investors. Book with your work email.
Guangzhou Magpie Pharmaceuticals Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Guangzhou Magpie Pharmaceuticals Co., Ltd.'s valuation, stock price, and market status.
Is Guangzhou Magpie Pharmaceuticals Co., Ltd. a public or private company?
Guangzhou Magpie Pharmaceuticals Co., Ltd. is a private company.
What is the current stock price of Guangzhou Magpie Pharmaceuticals Co., Ltd.?
Guangzhou Magpie Pharmaceuticals Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Guangzhou Magpie Pharmaceuticals Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Guangzhou Magpie Pharmaceuticals Co., Ltd. worth (valuation)?
Guangzhou Magpie Pharmaceuticals Co., Ltd.'s valuation is estimated at $123.9M based on funding round data.
Can I buy Guangzhou Magpie Pharmaceuticals Co., Ltd. stock?
Guangzhou Magpie Pharmaceuticals Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Guangzhou Magpie Pharmaceuticals Co., Ltd.'s last funding round?
Guangzhou Magpie Pharmaceuticals Co., Ltd.'s most recent funding round was Early Funding on April 20, 2020.
Who are the main investors in Guangzhou Magpie Pharmaceuticals Co., Ltd.?
Key investors in Guangzhou Magpie Pharmaceuticals Co., Ltd. include Shenzhen Sangel Venture Capital.
Will Guangzhou Magpie Pharmaceuticals Co., Ltd. IPO soon?
No public IPO plans have been announced for Guangzhou Magpie Pharmaceuticals Co., Ltd..
How can I track Guangzhou Magpie Pharmaceuticals Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Guangzhou Magpie Pharmaceuticals Co., Ltd.'s shares on secondary markets.